Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Curtin University
- Monash University
- Murdoch University
- Queensland University of Technology
- University of Adelaide
- University of Southern Queensland
- University of Melbourne
- CSIRO
- Flinders University
- La Trobe University
- Nature Careers
- Swinburne University of Technology
- The University of Newcastle
- 3 more »
- « less
-
Field
-
Status: Closed Applications open: 1/07/2024 Applications close: 18/08/2024 View printable version [.pdf] About this scholarship Description/Applicant information Project Overview Elements preserved
-
Australian police custody and young people. The project is a component of Dr Shelley Walker’s Australian Research Council (ARC) Discovery Early Career Research Award (#DE240101056 ). The National Drug Research
-
risk factor for a variety of mental health disorders, including depression, anxiety, eating disorders, substance use, and personality disorders. Around 10% of the general population have problematically
-
focussed on supporting a student to work on cutting edge research in collaboration with Kurloo and CSIRO with a pathway to commercialisation of the research outcomes. The industry engagement component of
-
also not be in receipt of any other scholarship. Essential: English language IELTS level of 7 and above Essential: Successful completion of an Honours or Masters programme with a research component (or
-
innovation and excellence. We aim to see our finite funding resources leveraged as much as possible, supporting the best Australian-based projects and researchers. Tour de Cure is a cancer agnostic
-
a three-month industry engagement component with the industry partner (Toowoomba Grammar School). Value Stipend of AUD $47,000 Maximum period of tenure of an award is 4 years. Periods of study already
-
-ray speckle-based imaging, a simple and flexible technique using just a piece of sandpaper as an optical element to access the phase-contrast and dark-field image modalities. Using this method, I
-
HH pathway element Smoothened (Smo) in a way that differs from cyclopamine and other Smo inhibitors. However, its limited water solubility impedes achieving adequate drug concentrations across
-
and Development package of $13,000 per annum. In addition, this program offers: A 60-day Industry Engagement component with the industry partner (Gold Hydrogen Limited), and A structured professional